omniture
logo
Search
RemeGen Co., Ltd
Media Room

Latest News

rss

Biotech Company RemeGen Commemorates International Self-Care Day with Health Initiatives

YANTAI, China, July 25, 2022 /PRNewswire/ -- The 24th of July marks International Self Care Day, hi...

2022-07-25 11:00 1802

RemeGen to Present Three Studies on Disitamab Vedotin at 2022 ASCO Annual Meeting

YANTAI, China, May 23, 2022  /PRNewswire/ -- RemeGen Co., Ltd. (9995.HK, SHA: 688331), a commercial...

2022-05-24 10:27 1776

RemeGen's Telitacicept Demonstrates Positive Results in Phase II Trial in Treatment of Primary Sjögren's Syndrome

YANTAI, China, Jan. 26, 2022 /PRNewswire/ -- RemeGen Co., Ltd. (9995.HK), a commercial-ready biotec...

2022-01-26 10:52 2992

RemeGen's Telitacicept Demonstrates Positive Results in Phase II Trial in Treatment of Primary Sjögren's Syndrome

YANTAI, China, Jan. 24, 2022 /PRNewswire/ -- RemeGen Co., Ltd. (9995.HK), a commercial-ready biotec...

2022-01-25 09:00 3047

RemeGen Reiterates Commitment to Its Battle Against Autoimmune Disease on World Strengthened Immunity Day 2021

YANTAI, China, Dec. 15, 2021 /PRNewswire/ -- To celebrate World Strengthened Immunity Day, RemeGen ...

2021-12-15 09:35 2272

RemeGen's Telitacicept and Disitamab Vedotin Enter China's National Reimbursement Drug List for SLE and Gastric Cancer Treatment

YANTAI, China, Dec. 3, 2021 /PRNewswire/ -- RemeGen Co., Ltd. (9995.HK), a commercial-ready biotech...

2021-12-03 13:45 3287
12